Noonan syndrome but is known to belong to the spectrum of less common cardiac anomalies in RASopathies. Three patients in their small cohort had postnatal chylothorax or lymphedema, providing additional evidence that RIT1 mutations confer a particular risk to lymphatic complications. This communication further underlines the importance of a thorough cardiologic follow-up and awareness of lymphatic anomalies in patients with Noonan syndrome in general and in those with RIT1 mutations specifically.
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